| |
| |
|
| Insider
Information: |
Mohanty Aditya P. |
| Relationship: |
|
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,640,876 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,221,403 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,640,876 |
|
|
| Total
Value |
$1,221,403 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lineage Cell Therapeutics Ord Shs |
LCTX |
Co-Chief Executive Off... |
2018-07-10 |
101,384 |
2016-04-11 |
0 |
Premium* |
|
|
Biora Therapeutics Ord Shs |
BIOR |
|
2024-02-15 |
1,539,492 |
2021-11-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
819,000 |
1,539,492 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
559,450 |
720,492 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2023-08-15 |
4 |
D |
$3.14 |
$370,146 |
D/D |
(117,881) |
161,042 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• – – |
2023-05-15 |
4 |
D |
$3.35 |
$37,684 |
D/D |
(11,249) |
278,923 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
D |
$2.56 |
$56,965 |
D/D |
(22,252) |
290,172 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
200,429 |
312,424 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2023-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(178) |
0 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2022-11-15 |
4 |
D |
$0.27 |
$47,269 |
D/D |
(175,071) |
2,799,858 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2022-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,562,500 |
2,974,929 |
0 |
- |
|
| BIOR |
Biora Therapeutics Ord Sh... |
Chief Executive Officer |
• • – |
2021-11-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,412,429 |
1,412,429 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-07-10 |
4 |
D |
$2.20 |
$3,566 |
D/D |
(1,621) |
101,384 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
103,005 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-04-10 |
4 |
D |
$2.49 |
$4,039 |
D/D |
(1,622) |
98,318 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,688 |
99,940 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-01-10 |
4 |
D |
$2.68 |
$5,513 |
D/D |
(2,057) |
95,252 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2018-01-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
97,309 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-10-10 |
4 |
D |
$2.81 |
$4,951 |
D/D |
(1,762) |
92,622 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-10-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,688 |
94,384 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-08-21 |
4 |
B |
$2.50 |
$18,750 |
D/D |
7,500 |
89,696 |
2.81 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
83,958 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-07-10 |
4 |
D |
$3.09 |
$5,445 |
D/D |
(1,762) |
82,196 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-04-10 |
4 |
D |
$3.33 |
$23,463 |
D/D |
(7,046) |
79,271 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2017-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
86,317 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2016-04-11 |
4 |
A |
$2.96 |
$199,998 |
D/D |
67,567 |
67,567 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Co-Chief Executive Officer |
• • – |
2016-04-11 |
4 |
A |
$2.96 |
$199,998 |
D/D |
67,567 |
67,567 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
